Literature DB >> 598402

Effect of clonidine on sleep patterns in man.

A Autret, M Minz, T Beillevaire, H P Cathala, H Schmitt.   

Abstract

Clonidine (300 microgram orally) increased in man the total duration of sleep and strikingly reduced the duration of REM sleep. Yohimbine (10 mg per os) did not alter the sleep patterns in man but antagonized the effects of clonidine. These results provide evidence that an alpha sympathomimetic mechanism could suppress REM sleep and increased the total duration of sleep.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 598402     DOI: 10.1007/bf00562444

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  A study of the central effects of sympathomimetic drugs: EEG and behavioural investigations on clonidine and naphazoline.

Authors:  V Florio; L Bianchi; V G Lonogo
Journal:  Neuropharmacology       Date:  1975-10       Impact factor: 5.250

2.  Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.

Authors:  N E Andén; M Grabowska; U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

3.  Sedative effects of alpha-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs.

Authors:  B Delbarre; H Schmitt
Journal:  Eur J Pharmacol       Date:  1971       Impact factor: 4.432

4.  Evidence for a central noradrenaline receptor stimulation by clonidine.

Authors:  N E Andén; H Corrodi; K Fuxe; B Hökfelt; T Hökfelt; C Rydin; T Svensson
Journal:  Life Sci       Date:  1970-05-01       Impact factor: 5.037

5.  Effects of some sympathomimetic amines administered intraventicularly on rabbit's EEG.

Authors:  Y Matsuda
Journal:  Jpn J Pharmacol       Date:  1969-03

6.  Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbine.

Authors:  P Bolme; H Corrodi; K Fuxe; T Hökfelt; P Lidbrink; M Goldstein
Journal:  Eur J Pharmacol       Date:  1974-09       Impact factor: 4.432

7.  Central effects of clonidine 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride in fowls.

Authors:  E Marley
Journal:  Br J Pharmacol       Date:  1975-12       Impact factor: 8.739

8.  Effects of catecholamines and adenosine derivatives given into the brain of fowls.

Authors:  E Marley; G Nistico
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

9.  Sleep produced by clonidine (2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride).

Authors:  R B Holman; E E Shillito; M Vogt
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

10.  Human sleep and 5-HTP. Effects of repeated high doses and of association with benserazide (RO.04.4602).

Authors:  A Autret; M Minz; B Bussel; H P Cathala; P Castaigne
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1976-10
View more
  7 in total

1.  α2-Adrenergic blockade rescues hypoglossal motor defense against obstructive sleep apnea.

Authors:  Gang Song; Chi-Sang Poon
Journal:  JCI Insight       Date:  2017-02-23

2.  Clonidine has a paradoxical effect on cyclic arousal and sleep bruxism during NREM sleep.

Authors:  Maria Clotilde Carra; Guido M Macaluso; Pierre H Rompré; Nelly Huynh; Liborio Parrino; Mario Giovanni Terzano; Gilles J Lavigne
Journal:  Sleep       Date:  2010-12       Impact factor: 5.849

3.  6-(3-chloro)-phenoxy-2-methyl-1-oxa-4-azospiro-[4,5]decane-3-one (CERM 3726) and sleep of healthy men.

Authors:  A N Nicholson; B M Stone
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 4.  Are the pharmacology and physiology of α₂ adrenoceptors determined by α₂-heteroreceptors and autoreceptors respectively?

Authors:  Ralf Gilsbach; Lutz Hein
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

5.  Effects of clonidine on breathing during sleep and susceptibility to central apnoea.

Authors:  Abdul Ghani Sankri-Tarbichi; Kevin Grullon; M Safwan Badr
Journal:  Respir Physiol Neurobiol       Date:  2012-09-24       Impact factor: 1.931

Review 6.  Melatonin supplementation for severe and intractable sleep disturbance in young people with genetically determined developmental disabilities: short review and commentary.

Authors:  J Turk
Journal:  J Med Genet       Date:  2003-11       Impact factor: 6.318

7.  Central effects of guanfacine and clonidine during wakefulness and sleep in healthy subjects.

Authors:  R Spiegel; J E DeVos
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.